Lysosomal proteases (cathepsins) were upregulated, and cathepsin D (CTSD) was increased at the mRNA, protein, and serum levels, suggesting CTSD as a candidate biomarker of advanced MASLD. The gene discussed is CTSD; the disease is metabolic dysfunction-associated steatotic liver disease.